Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis

Where the EU money came from

Funding by EU programme. Amounts are Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis's own share of each project, not the project's full budget.

Projects

163 EU-funded projects, newest first. Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis led 53 of them as coordinator. Each links to the official record.

• EXCELYPartner

  Excellence Center in Liquid BiopsY in Personalized Medicine (EXCELY)

  Horizon Europe · 2026–2032 · Project on CORDIS ↗

  €1.5Mtheir share
• ORFeusPartner

  Decoding the dark proteome through interdisciplinary training and research

  Horizon Europe · 2026–2030 · Project on CORDIS ↗

  €305ktheir share
• T-REaCTCoordinator

  Evolution of T cell reactivity against somatic mutations across human colon cancer stages with single-cell genomics and synthetic T cell specificity screening

  Horizon Europe · 2026–2028 · Project on CORDIS ↗

  €217ktheir share
• ENACT-65Partner

  ENabling ACTion on Integrated Nutritional and Exercise Care in Cancer – for Patients 65 and Beyond

  Horizon Europe · 2026–2031 · Project on CORDIS ↗

  €633ktheir share
• CLUSTER-TILCoordinator

  HARNESSING HETEROTYPIC T CELL CLUSTERS TO BOOST TIL CANCER THERAPY

  Horizon Europe · 2026–2028 · Project on CORDIS ↗

  €150ktheir share
• NeoEpiTarCoordinator

  In vivo targeting of neoepitopes induced by arginine deprivation in cancer

  Horizon Europe · 2026–2028 · Project on CORDIS ↗

  €150ktheir share
• GeneMotorsPartner

  Genome control by DNA-looping motors: from folding to function

  Horizon Europe · 2026–2032 · Project on CORDIS ↗

  €2.5Mtheir share
• DYNAMISAssociated partner

  IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions

  Horizon Europe · 2026–2030 · Project on CORDIS ↗
• Immuno-SBCCoordinator

  Disentangling the relationship between autoimmunity, cancer treatment, and risk of subsequent breast cancer

  Horizon Europe · 2026–2030 · Project on CORDIS ↗

  €1.3Mtheir share
• HER-CARECoordinator

  Hereditary and Early onset breast cancer: Comprehensive personalized Assessment, early Risk Evaluation, and clinical management

  Horizon Europe · 2026–2029 · Project on CORDIS ↗

  €916ktheir share
• JA PCMPartner

  Joint Action Personalised Cancer Medicine

  EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

  €1.5Mtheir share
• COMPASS-AIPartner

  Community Of Multidisciplinary Professionals Advancing Safe and Successful AI implementation in clinical practice

  EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

  €823ktheir share
• PERIFORMANCEPartner

  PUBLIC ENGAGEMENT IN RESEARCH INFRASTRUCTURES FOR MISSION CANCER: MANAGING COMPLEXITY OF EMERGING TECHNOLOGIES

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €74ktheir share
• PredictAYAPartner

  Prediction and prevention of late effects in AYA cancer survivors – An effort to understand, predict and prevent late effects in AYAs 15-39 years of age, with a focus on fertility and gonadal toxicity

  Horizon Europe · 2025–2030 · Project on CORDIS ↗

  €387ktheir share
• DYNACOFCoordinator

  Single-molecule visualization of transcription dynamics to understand regulatory mechanisms of cofactors

  Horizon Europe · 2025–2030 · Project on CORDIS ↗

  €2.0Mtheir share
• PRIM-TECH3RPartner

  Preclinical in vitro Models for the Replacement, Reduction and Refinement of Mouse Models in Preclinical Studies (PRIM-TECH3R)

  Horizon Europe · 2025–2028 · Project on CORDIS ↗

  €216ktheir share
• PanCare4AYAPartner

  Patient-centred, evidence-based late effect screening and follow-up care of survivors of adolescent and young adult cancer

  Horizon Europe · 2025–2030 · Project on CORDIS ↗

  €321ktheir share
• AdaptmetPartner

  Deconstructing adaptive evolution of metastasis

  Horizon Europe · 2025–2029 · Project on CORDIS ↗

  €274ktheir share
• CHEMOPROTECTCoordinator

  Using senolytic agents to suppress the toxicity of chemotherapy

  Horizon Europe · 2025–2026 · Project on CORDIS ↗

  €150ktheir share
• TF-KINETIXCoordinator

  Why do transcription factors bind what they bind when they bind?

  Horizon Europe · 2024–2029 · Project on CORDIS ↗

  €1.5Mtheir share
• JANE-2Associated partner

  Joint Action on Networks of Expertise on Cancer

  EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

  €633ktheir share
• EUnetCCC JAAssociated partner

  The European Comprehensive Cancer Centre Network

  EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

  €256ktheir share
• pepTalksCoordinator

  Causes and consequences of aberrant mRNA translation in cancer

  Horizon Europe · 2024–2029 · Project on CORDIS ↗

  €2.5Mtheir share
• DeepGeneticsCoordinator

  Deep genetics to study and uncover ‘hidden’ biology

  Horizon Europe · 2024–2029 · Project on CORDIS ↗

  €2.5Mtheir share
• PARADOXCoordinator

  Paradoxical activation of oncogenic signaling as a cancer treatment strategy.

  Horizon Europe · 2024–2029 · Project on CORDIS ↗

  €2.5Mtheir share
• INFRAPLUSPartner

  Enhancing and Evolving INFRAFRONTIER Disease Modelling Capacity to Enable Breakthrough Research

  Horizon Europe · 2024–2027 · Project on CORDIS ↗

  €110ktheir share
• Cat4CanCenterPartner

  Catalysis for Cancer Treatment.

  Horizon Europe · 2024–2029 · Project on CORDIS ↗

  €3.6Mtheir share
• HoloSurgePartner

  Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers

  Horizon Europe · 2024–2027 · Project on CORDIS ↗

  €1.5Mtheir share
• IMPROVEPartner

  Framework to IMPROVE the Integration of Patient Generated Health Data to Facilitate Value Based Healthcare

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €662ktheir share
• PRIME-ROSEPartner

  PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €267ktheir share
• STREXIT2Partner

  A PRAGMATIC CLINICAL STUDY OF NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VERSUS SURGERY ALONE FOR PATIENTS WITH HIGH RISK RETROPERITONEAL SARCOMA

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €95ktheir share
• CCI4EUAssociated partner

  COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

  Horizon Europe · 2023–2026 · Project on CORDIS ↗
• CARE1Partner

  First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €281ktheir share
• PragmaTILPartner

  Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €913ktheir share
• RepStatePartner

  DNA Repair State Machines

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €274ktheir share
• ESPERANCEPartner

  ERA Chair Life Sciences Program to EmpoweR moleculAr aNd struCtural biology initiativEs at UPAT

  Horizon Europe · 2023–2028 · Project on CORDIS ↗

  €573ktheir share
• Fragment-ScreenPartner

  From fragments to high affinity binders interfacing integrated structural biology, medicinal chemistry and artificial intelligence

  Horizon Europe · 2023–2027 · Project on CORDIS ↗

  €270ktheir share
• flIMAGIN3DPartner

  Doctoral Network for a Shared Excellence of Fluorescent Lifetime Imaging Microscopy in Biomedical Applications

  Horizon Europe · 2023–2026 · Project on CORDIS ↗

  €274ktheir share
• Maxima ButterflyAssociated partner

  From Caterpillar to BUTTERFLY: supporting transformation of DCs in a paediatric oncology network

  Horizon Europe · 2023–2027 · Project on CORDIS ↗
• EUonQoLPartner

  Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe

  Horizon Europe · 2023–2026 · Project on CORDIS ↗

  €173ktheir share

Showing the 80 most recent of 163 projects.

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Karolinska InstitutetSweden · 33 shared projects
• Erasmus Universitair Medisch Centrum RotterdamNetherlands · 26 shared projects
• Centre National de la Recherche Scientifique CNRSFrance · 25 shared projects
• Institut National de la Sante et de la Recherche MedicaleFrance · 23 shared projects
• European Molecular Biology LaboratoryGermany · 23 shared projects
• Academisch Ziekenhuis LeidenNetherlands · 22 shared projects
• Katholieke Universiteit LeuvenBelgium · 21 shared projects
• Deutsches Krebsforschungszentrum HeidelbergGermany · 20 shared projects
• Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio)Spain · 18 shared projects
• Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 17 shared projects
• Academisch Ziekenhuis GroningenNetherlands · 17 shared projects
• Institut CurieFrance · 15 shared projects
• Oslo Universitetssykehus HfNorway · 15 shared projects
• Institut Gustave RoussyFrance · 15 shared projects
• Masarykova univerzitaCzech Republic · 14 shared projects
• The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 13 shared projects

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• DNA viruses
• RNA
• amines
• amorphous semiconductors
• anatomy and morphology
• animal husbandry
• antivirals
• arteriosclerosis
• artificial intelligence
• autoimmune diseases
• bacteriology
• big data
• biochemistry